TRIN

$14.59

Market ClosedAs of Mar 17, 8:00 PM UTC

Trinity Capital Inc.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JPMBACGS

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$14.59
Potential Upside
188.4%
Whystock Fair Value$42.08
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorFinancial Services
IndustryAsset Management

Trinity Capital Inc. is a business development company specializing in term loans, equipment financing, and private equity-related investments. The firm provides tech lending, equipment financing, life sciences, warehouse lending, and sponsor finance...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.21B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
7.22
Beta
Defensive asset. Lower volatility than the S&P 500.
0.64
Div Yield
Strong income play. Yield provides a meaningful total return floor.
1798.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
14.15%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.45

Recent News

Simply Wall St.
Mar 17, 2026

Trinity Capital JV Targets Senior Secured Debt And Income Mix Shift

Trinity Capital and Capital Southwest have formed a joint venture to invest in first out senior secured debt in the lower middle market. The partnership aims to expand Trinity Capital's lending platform into a new segment of secured lending. The joint venture introduces a fresh source of potential deal flow and fee income for both partners. Trinity Capital, listed as NasdaqGS:TRIN, is entering this new partnership with its shares trading at about $14.18. The stock has seen a 4.6% gain over...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
24/7 Wall St.
Mar 16, 2026

There Are BDCs Paying 14% to 27% Yields But Only A Few That Can Actually Sustain It

Three business development companies are flashing yields that stop income investors cold: FS KKR Capital Corp (NYSE:FSK) at 26.5%, Stellus Capital Investment (NYSE:SCM) at 16.7%, and Trinity Capital (NASDAQ:TRIN) at 13.7%. Yields that high are either an opportunity or a warning. In this case, the answer depends heavily on which BDC you are looking at. ... There Are BDCs Paying 14% to 27% Yields But Only A Few That Can Actually Sustain It

BEARISH
Negative press. News cycle fixated on risk factors or misses.
24/7 Wall St.
Mar 16, 2026

The S&P 500 Dropped 2.5% and These 2 Closed-End Funds Held Their Ground

The S&P 500 has dropped roughly 2.5% over the past month, with the VIX fear gauge sitting at 27.29 as of mid-March, reflecting the kind of elevated uncertainty that rattles growth-heavy portfolios. For income-focused investors, two names worth understanding in this context are Gabelli Multimedia Trust (NYSE:GGT) and Trinity Capital (NASDAQ:TRIN), both of which have ... The S&P 500 Dropped 2.5% and These 2 Closed-End Funds Held Their Ground

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Mar 14, 2026

Assessing Trinity Capital (TRIN) Valuation After Recent Share Price Weakness

Event driven look at Trinity Capital Trinity Capital (TRIN) has drawn investor attention after recent share price pressure, including a 1.8% decline on the latest close and negative returns over the past week, month, and past 3 months. With the stock at US$14.42 and a reported intrinsic discount of 46.13%, some investors are reassessing how the company’s business development model and private credit exposure align with their income and total return goals. See our latest analysis for Trinity...

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Mar 14, 2026

Trinity Capital Deepens MedTech Lending As Commercialization Risks And Rewards Grow

Trinity Capital (NasdaqGS:TRIN) has committed new growth capital to three MedTech companies: Neuros Medical, Emboline, and Monteris Medical. The funding is intended to support commercialization of devices focused on post amputation pain, stroke risk during heart procedures, and minimally invasive neurosurgery. These commitments expand Trinity Capital's presence in growth stage healthcare lending and highlight fresh activity in its specialty finance platform. Trinity Capital, trading at...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.